Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline Full Text
Annals of Internal Medicine,  Evidence Based Medicine  Clinical Article

Fink HA et al. – The role of chronic kidney disease (CKD) screening or monitoring in improving clinical outcomes is uncertain. Evidence for CKD treatment benefit is strongest for angiotensin–converting enzyme inhibitors and angiotensin II–receptor blockers, and in patients with albuminuria combined with diabetes or cardiovascular disease.

Methods
  • MEDLINE (1985 through November 2011), reference lists, and expert suggestions.
  • English–language, randomized, controlled trials that evaluated screening for or monitoring or treatment of CKD and that reported clinical outcomes.
  • Two reviewers assessed study characteristics and rated quality and strength of evidence.
  • No trials evaluated screening or monitoring, and 110 evaluated treatments.

Results
  • Angiotensin–converting enzyme inhibitors (relative risk, 0.65 [95% CI, 0.49 to 0.88]) and angiotensin II–receptor blockers (relative risk, 0.77 [CI, 0.66 to 0.90]) reduced end–stage renal disease versus placebo, primarily in patients with diabetes who have macroalbuminuria.
  • Angiotensin–converting enzyme inhibitors reduced mortality versus placebo (relative risk, 0.79 [CI, 0.66 to 0.96]) in patients with microalbuminuria and cardiovascular disease or high–risk diabetes.
  • Statins and β–blockers reduced mortality and cardiovascular events versus placebo or control in patients with impaired estimated glomerular filtration rate and either hyperlipidemia or congestive heart failure, respectively.
  • Risks for mortality, end–stage renal disease, or other clinical outcomes did not significantly differ between strict and usual blood pressure control.
  • The strength of evidence was rated high for angiotensin II–receptor blockers and statins, moderate for angiotensin–converting enzyme inhibitors and β–blockers, and low for strict blood pressure control.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Vancomycin-resistant enterococci colonization among dialysis patients: A meta-analysis of prevalence, risk factors, and significance American Journal of Kidney Diseases, July 18, 2014    Review Article

2 Meta-analysis of the effect of statins on renal function The American Journal of Cardiology, August 7, 2014    Evidence Based Medicine    Review Article    Clinical Article

3 APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes Kidney International, July 25, 2014    Clinical Article

4 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

5 Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: The PREDIAN trial Journal of the American Society of Nephrology, June 30, 2014    Clinical Article

6 Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia Clinical Kidney Journal, August 1, 2014    Clinical Article

7 Magnesium retards the progress of the arterial calcifications in hemodialysis patients: A pilot study International Urology and Nephrology, August 15, 2014    Clinical Article

8 Effects of fish oil on serum lipid profile in dialysis patients: a systematic review and meta-analysis of randomized controlled trials Full Text Lipids in Health and Disease, August 11, 2014    Free full text    Evidence Based Medicine    Clinical Article

9 A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial American Journal of Kidney Diseases, August 11, 2014    Clinical Article

10 Effect of omega-3 fatty acids on kidney function after myocardial infarction: The Alpha Omega Trial Clinical Journal of the American Society of Nephrology, August 12, 2014    Clinical Article
Exclusive Author Commentary

11 ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010 American Journal of Kidney Diseases, August 18, 2014    Clinical Article

12 Cost-minimization analysis of lanthanum carbonate versus sevelamer hydrochloride in US patients with end-stage renal disease Clinical Therapeutics, August 5, 2014    Clinical Article

13 Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: A proportional meta-analysis Full Text BMC Infectious Diseases, August 19, 2014    Free full text    Evidence Based Medicine    Clinical Article

14 Effects of spironolactone on dialysis patients with refractory hypertension: a randomized controlled study The Journal of Clinical Hypertension, July 23, 2014    Clinical Article

15 Improving clinical outcomes among hemodialysis patients: A proposal for a volume first approach from the chief medical officers of US dialysis providers American Journal of Kidney Diseases, August 25, 2014    Clinical Article

16 Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis Full Text PLoS Medicine, August 14, 2014    Free full text    Evidence Based Medicine    Review Article

17 Aldosterone blockade in chronic kidney disease Seminars in Nephrology, July 14, 2014    Clinical Article

18 Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Kidney International, July 11, 2014    Clinical Article

19 Serum metabolomic profiling and incident CKD among African Americans Clinical Journal of the American Society of Nephrology, August 13, 2014    Clinical Article

20 Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis Clinical Journal of the American Society of Nephrology, July 1, 2014    Clinical Article

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close